Literature DB >> 22047632

Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray?

Tyler A Kokjohn1, Chera L Maarouf, Alex E Roher.   

Abstract

Here, we synthesize several lines of evidence supporting the hypothesis that at least one function of amyloid-β is to serve as a part of the acute response to brain hemodynamic disturbances intended to seal vascular leakage. Given the resilient and adhesive physicochemical properties of amyloid, an abluminal hemostatic repair system might be highly advantageous, if deployed on a limited and short-term basis, in young individuals. However, in the aged, inevitable cardiovascular dysfunction combined with brain microvascular lesions may yield global chronic hypoperfusion that may lead to continuous amyloid deposition and consequential negative effects on neuronal viability. A large body of experimental evidence supports the hypothesis of an amyloid-β rescue function gone astray. Preventing or inducing the removal of amyloid in Alzheimer's disease (AD) has been simultaneously successful and disappointing. Amyloid deposits clearly play major roles in AD, but they may not represent the preeminent factor in dementia pathogenesis. Successful application of AD preventative approaches may hinge on an accurate and comprehensive view of comorbidities, including cardiovascular disease, diabetes, and head trauma.
Copyright © 2012 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22047632      PMCID: PMC3984046          DOI: 10.1016/j.jalz.2011.05.2429

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  121 in total

Review 1.  A vascular connection to Alzheimer's disease.

Authors:  J A Rhodin; T Thomas
Journal:  Microcirculation       Date:  2001-08       Impact factor: 2.628

Review 2.  Proinflammatory and vasoactive effects of Abeta in the cerebrovasculature.

Authors:  K P Townsend; D Obregon; A Quadros; N Patel; Ch Volmar; D Paris; M Mullan
Journal:  Ann N Y Acad Sci       Date:  2002-11       Impact factor: 5.691

3.  Neurodegeneration and the neurovascular unit.

Authors:  Berislav V Zlokovic
Journal:  Nat Med       Date:  2010-12       Impact factor: 53.440

4.  Anti-Tumoral Activity of a Short Decapeptide Fragment of the Alzheimer's Abeta Peptide.

Authors:  Daniel Paris; Nikunj Patel; Nowell J Ganey; Vincent Laporte; Amita Quadros; Michael J Mullan
Journal:  Int J Pept Res Ther       Date:  2010       Impact factor: 1.931

Review 5.  An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease.

Authors:  J A Hardy; D M Mann; P Wester; B Winblad
Journal:  Neurobiol Aging       Date:  1986 Nov-Dec       Impact factor: 4.673

6.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

7.  Decreased cerebral blood flow and prognosis of Alzheimer's disease: a multicenter HMPAO-SPECT study.

Authors:  Tsunehiko Nishimura; Kazuo Hashikawa; Hidenao Fukuyama; Takao Kubota; Shin Kitamura; Hiroshi Matsuda; Haruo Hanyu; Hidehiko Nabatame; Naohiko Oku; Hirotaka Tanabe; Yasuo Kuwabara; Seishi Jinnouchi; Atsushi Kubol
Journal:  Ann Nucl Med       Date:  2007-01       Impact factor: 2.668

Review 8.  Cerebrovascular requirement for sealant, anti-coagulant and remodeling molecules that allow for the maintenance of vascular integrity and blood supply.

Authors:  Craig S Atwood; Richard L Bowen; Mark A Smith; George Perry
Journal:  Brain Res Brain Res Rev       Date:  2003-09

9.  Transcranial doppler ultrasound blood flow velocity and pulsatility index as systemic indicators for Alzheimer's disease.

Authors:  Alex E Roher; Zsolt Garami; Suzanne L Tyas; Chera L Maarouf; Tyler A Kokjohn; Marek Belohlavek; Linda J Vedders; Donald Connor; Marwan N Sabbagh; Thomas G Beach; Mark R Emmerling
Journal:  Alzheimers Dement       Date:  2011-03-09       Impact factor: 21.566

Review 10.  Alzheimer's disease is a vasocognopathy: a new term to describe its nature.

Authors:  Jack C de la Torre
Journal:  Neurol Res       Date:  2004-07       Impact factor: 2.448

View more
  7 in total

1.  A Cross-Sectional Analysis of Late-Life Cardiovascular Factors and Their Relation to Clinically Defined Neurodegenerative Diseases.

Authors:  Brittany N Dugger; Michael Malek-Ahmadi; Sarah E Monsell; Walter A Kukull; Bryan K Woodruff; Eric M Reiman; Thomas G Beach; Jeffrey Wilson
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Jul-Sep       Impact factor: 2.703

2.  Neurochemical profile of dementia pugilistica.

Authors:  Tyler A Kokjohn; Chera L Maarouf; Ian D Daugs; Jesse M Hunter; Charisse M Whiteside; Michael Malek-Ahmadi; Emma Rodriguez; Walter Kalback; Sandra A Jacobson; Marwan N Sabbagh; Thomas G Beach; Alex E Roher
Journal:  J Neurotrauma       Date:  2013-06-01       Impact factor: 5.269

Review 3.  A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease.

Authors:  Francesco Panza; Bruno P Imbimbo; Madia Lozupone; Giancarlo Logroscino
Journal:  Nat Rev Neurol       Date:  2019-02       Impact factor: 42.937

4.  Interactions between amyloid-β and hemoglobin: implications for amyloid plaque formation in Alzheimer's disease.

Authors:  Jia-Ying Chuang; Chu-Wan Lee; Yao-Hsiang Shih; Tingting Yang; Lung Yu; Yu-Min Kuo
Journal:  PLoS One       Date:  2012-03-06       Impact factor: 3.240

5.  Morphological and pathological evolution of the brain microcirculation in aging and Alzheimer's disease.

Authors:  Jesse M Hunter; Jason Kwan; Michael Malek-Ahmadi; Chera L Maarouf; Tyler A Kokjohn; Christine Belden; Marwan N Sabbagh; Thomas G Beach; Alex E Roher
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

6.  Bapineuzumab alters aβ composition: implications for the amyloid cascade hypothesis and anti-amyloid immunotherapy.

Authors:  Alex E Roher; David H Cribbs; Ronald C Kim; Chera L Maarouf; Charisse M Whiteside; Tyler A Kokjohn; Ian D Daugs; Elizabeth Head; Carolyn Liebsack; Geidy Serrano; Christine Belden; Marwan N Sabbagh; Thomas G Beach
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.240

7.  Biochemical assessment of precuneus and posterior cingulate gyrus in the context of brain aging and Alzheimer's disease.

Authors:  Chera L Maarouf; Tyler A Kokjohn; Douglas G Walker; Charisse M Whiteside; Walter M Kalback; Alexis Whetzel; Lucia I Sue; Geidy Serrano; Sandra A Jacobson; Marwan N Sabbagh; Eric M Reiman; Thomas G Beach; Alex E Roher
Journal:  PLoS One       Date:  2014-08-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.